Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANSBingnan Zhang, Laura Alder, Samuel Rosner, et al.
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Science (New York, N.Y.)|February 26, 2016
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsGregory V Kryukov, Frederick H Wilson, Jason R Ruth, et al.
The Lancet. Oncology|April 7, 2020
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trialSarah B Goldberg, Kurt A Schalper, Scott N Gettinger, et al.
JTO Clinical and Research Reports|November 14, 2025
Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLCKai-Lin Liu, Alex Watts, Connor B Grady, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2018
Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung CancerMagda Bahcall, Mark M Awad, Lynette M Sholl, et al.
JMIR Cancer|May 19, 2022
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational StudyMaitri Kalra, Elizabeth Henry, Kelly McCann, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2017
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine studyArezou A Ghazani, Nelly M Oliver, Joseph P St Pierre, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort StudyAmin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.
Pageof 4